Close Menu

NEW YORK (GenomeWeb) – Agena Bioscience and Molecular Health said today that they have entered into a strategic partnership under which Molecular Health will use its MH Guide analysis platform to interpret raw data generated by Agena's MassArray system.

The relationship is part of Agena's MassArray Insights reporting network, under which the firm seeks to collaborate with various molecular analysis platform providers.

Specific terms of the agreement were not disclosed, but the firms said that they plan to "cooperate and collaborate with their respective customer bases."

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The UK and the European Union have come to a sticking point in the negotiation of how the UK might remain involved in the Horizon Europe research program, the Guardian reports.

The New York Times reports that experts pushed during a meeting of an FDA advisory board for the agency to require more safety data from SARS-CoV-2 vaccine trials.

The Washington Post reports Moderna expects that it will have enough data on its candidate SARS-CoV-2 vaccine to submit to regulatory authorities by mid-November.

In Science this week: ANXA11 variants affect calcium homeostasis and stress granule disassembly in ALS, and more.